Disease/Infection News

RSS

EMA's CHMP issues positive opinion for Cangene's Human Hepatitis B Immunoglobulin product

Cangene Corporation today reports that it has received a positive opinion from the EMA's Committee for Medicinal Products for Human Use ("CHMP") regarding the immunoprophylaxis indication of Cangene's ImmunoGam(TM) (Human Hepatitis B Immunoglobulin).

18 Dec 2009

PolyMedix completes first two segments of its PMX-30063 antibiotic drug candidate Phase 1B study

PolyMedix, Inc., an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, has successfully completed the first two segments of a Phase 1B clinical safety study with its novel antibiotic drug candidate PMX-30063.

18 Dec 2009

Flamel Technologies initiates IFN-alpha-2b XL Phase 2a clinical trial for HCV

Flamel Technologies today announced the initiation of a Phase 2a clinical trial of Flamel’s Interferon alpha-2b XL (IFN-alpha-2b XL), which is based on Flamel’s Medusa® platform for controlled release of biologics. IFN-alpha-2b XL is being developed as a controlled release of unmodified interferon alpha-2b for the treatment of chronic hepatitis C virus (HCV).

18 Dec 2009

Congress lifts federal ban on needle exchange programs

The Minnesota Independent: "An appropriations bill passed by Congress last weekend is being hailed by public health advocates for ending funding for abstinence-until-marriage sex education and eliminating the ban on federal funding for needle exchange programs" (Birkey, 12/17).

18 Dec 2009

Safe living guidelines for transplant recipients

Keeping pets healthy can reduce infection risks for people who have received solid organ transplants and veterinarians should be seen as an integral part of the healthcare team. That's just one of the key pieces of advice from a safe living article published in an infectious diseases supplement in the American Journal of Transplantation.

18 Dec 2009

Many states still lack the 21st century technology capacity needed for disease surveillance

Today, CDC's Morbidity and Mortality Weekly Report (MMWR) released a report showing that the number of state-level epidemiologists has decreased steadily since 2004, with a marked decline of over 10% since 2006.

18 Dec 2009

Government not held accountable for keeping nurses safe during SARS, Supreme Court denies appeal

Registered nurses in Ontario are devastated today to learn that the Supreme Court of Canada has denied an appeal of an earlier legal decision regarding responsibility for keeping nurses safe during the SARS outbreak.

18 Dec 2009

Human protein may help prevent H1N1 infection

Howard Hughes Medical Institute researchers have identified a naturally occurring human protein that helps prevent infection by H1N1 influenza and other viruses, including West Nile and dengue virus.

18 Dec 2009

AHF praises California Assembly members' initiative to protect state’s AIDS drug program funding

AIDS Healthcare Foundation (AHF) today praised the action taken by thirty-eight members of the California Assembly who, in a signed letter, urged Governor Schwarzenegger to protect funding for California’s AIDS Drug Assistance Program (ADAP). The Governor, who is currently completing his 2010-11 budget, could propose up to $70 million in cuts to ADAP in his upcoming budget, a move which, if enacted, will gut the state’s lifesaving AIDS drug program currently serving more than 35,000 low-income Californians living with HIV/AIDS.

18 Dec 2009

Immuno Laboratories and TRPN sign agreement to reduce chronic illness

Immuno Laboratories, a leading provider of food and environmental allergy testing services, announced an agreement with Three Rivers Provider Network (TRPN), the largest and fastest growing proprietary Preferred Provider Organization (PPO) network in the United States.

18 Dec 2009

New WHO report shows considerable progress in malaria

According to the World Health organization’s World Malaria Report 2009 released earlier this week, more than one third of affected countries included in the study have witnessed reduction in malaria cases by more than 50 percent between 2000 and 2008.

18 Dec 2009

Bill & Melinda Gates Foundation grants funds for visceral leishmaniasis research

The Hebrew University of Jerusalem Kuvin Center for the Study of Infectious and Tropical Diseases has received a $5 million grant from the Bill & Melinda Gates Foundation for research into visceral leishmaniasis.

18 Dec 2009

Genetic variant associated with reduced risk of COPD

What: Researchers have discovered evidence that suggests a genetic variant may be associated with better preserved lung function among children with asthma and adults who smoke, according to a new study funded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health.

18 Dec 2009

Flu-fighting proteins found in human cells stop flu virus, uncover scientists

In findings that may lead to better ways to prevent and treat influenza and other viral infections, researchers report the discovery of a family of naturally occurring antiviral agents in human cells.

18 Dec 2009

Comprehensive approaches to understand the interaction of H1N1 strains with human cells

Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.

18 Dec 2009

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

17 Dec 2009

Update on Phase 2 clinical trial of oral interferon announced by Amarillo Biosciences

Amarillo Biosciences, Inc. (ABI) today announced that its ongoing study of oral interferon as prevention/treatment of influenza and other respiratory illnesses in Perth, Australia is nearing completion.

17 Dec 2009

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases - tuberculosis, malaria and dengue virus -- in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders.

17 Dec 2009

PEPFAR decisions to be grounded in scientific evidence, Goosby says

U.S. Global AIDS Coordinator Eric Goosby "said future programmes to prevent HIV infection would be those supported by the best scientific evidence," reports the Financial Times. Goosby told the Financial Times in an interview: "I will always wrap myself in the science as the justification of decision-making. I will not factor in an ideological rationale."

17 Dec 2009

African AIDS vaccine conference addresses future trials in Africa, lower participation rates among women

During the Forum of the African AIDS Vaccine Program (AAVP) in Kampala, Uganda, on Wednesday, Alan Bernstein, the director of the Global HIV Vaccine Enterprise, discussed ongoing efforts to launch an experimental HIV vaccine trial - similar to the recent trial in Thailand - in Africa, the Daily Monitor reports.

17 Dec 2009

Disease/Infection News

EMA's CHMP issues positive opinion for Cangene's Human Hepatitis B Immunoglobulin product

PolyMedix completes first two segments of its PMX-30063 antibiotic drug candidate Phase 1B study

Flamel Technologies initiates IFN-alpha-2b XL Phase 2a clinical trial for HCV

Congress lifts federal ban on needle exchange programs

Safe living guidelines for transplant recipients

Many states still lack the 21st century technology capacity needed for disease surveillance

Government not held accountable for keeping nurses safe during SARS, Supreme Court denies appeal

Human protein may help prevent H1N1 infection

AHF praises California Assembly members' initiative to protect state’s AIDS drug program funding

Immuno Laboratories and TRPN sign agreement to reduce chronic illness

New WHO report shows considerable progress in malaria

Bill & Melinda Gates Foundation grants funds for visceral leishmaniasis research

Genetic variant associated with reduced risk of COPD

Flu-fighting proteins found in human cells stop flu virus, uncover scientists

Comprehensive approaches to understand the interaction of H1N1 strains with human cells

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

Update on Phase 2 clinical trial of oral interferon announced by Amarillo Biosciences

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

PEPFAR decisions to be grounded in scientific evidence, Goosby says

African AIDS vaccine conference addresses future trials in Africa, lower participation rates among women

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News